NCT02867124View on ClinicalTrials.gov

Long-acting Naltrexone for Pre-release Prisoners

PHASE3RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

February 1, 2025

Study Completion Date

June 1, 2025

Conditions
Opiate Addiction
Interventions
DRUG

XR-NTX

Vivitrol

OTHER

place of residence

One injection of XR-NTX in prison, followed by 6 monthly injections post-release at place of residence

OTHER

opioid treatment program

One injection of XR-NTX in prison, followed by 6 monthly injections post-release at a community opioid treatment program

Trial Locations (1)

21286

RECRUITING

Maryland Department of Public Safety and Correctional Services, Towson

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Friends Research Institute, Inc.

OTHER